| |||||||||
| These Liv-DGAT2-low transgenic mice may be useful in studying hepatic steatosis, lipid, glucose, and insulin metabolism, as well as obesity and diabetes. | |||||||||
Type Coisogenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered Mutant Mice. Mating System Noncarrier x Hemizygote (Female x Male) Species laboratory mouse Generation F?+N1+ (27-AUG-08) Donating Investigator Robert Farese, Jr., Gladstone Institute UCSF Description
Mice hemizygous for this LivLE6-DGAT2 transgene are viable and fertile, with human DGAT2 expression directed to the liver by the hepatic promoter/enhancer sequences from the human apolipoprotein E gene. Mice from founder line 24 (referred to as Liv-DGAT2-low) have an approximately 2-fold increase in total hepatic DGAT2 mRNA/protein expression, with no reported overexpression in kidney, brain, or skeletal muscle. As DGAT2 is one of two enzymes that catalyze the final step of triacylglycerol (TG) biosynthesis, transgenic mice develop hepatic steatosis with increased hepatic TG and insulin signaling lipid (diacylglycerol, ceramide and unsaturated Fatty AcylCoA) content. Liv-DGAT2-low mice also exhibit increased transcription of fatty acid synthesis genes (SREBP-1c, fatty acid synthase, and stearoyl CoA desaturase 1). Fasted mice show a 65% decrease in plasma TG, but are not insulin resistant (blood glucose and insulin are similar to wildtype). Liv-DGAT2-low mice challenged with a high-fat diet do not exhibit impaired glucose or insulin tolerance more than that found in control mice. These Liv-DGAT2-low transgenic mice may be useful in studying hepatic steatosis, lipid, glucose, and insulin metabolism, as well as obesity and diabetes.Of note, these mice may also be useful in conjunction with MCK-DGAT2 transgenic mice (Stock No. 006781) which exhibit DGAT2 overexpression directed to glycolytic striated skeletal muscle.
Development
The LivLE6-DGAT2 transgene was designed with promoter and enhancer sequences of the human apolipoprotein E gene placed upstream of a 1.2 kb human acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2) cDNA sequence. This transgene was microinjected into C57BL/6NHsd fertilized eggs, and the resulting transgenic offspring were bred to C57BL/6NHsd. Founder line 24 (Liv-DGAT2-low) mice were established and maintained by breeding transgenic mice to C57BL/6NHsd for many generations prior to arrival at The Jackson Laboratory. Upon arrival, mice were bred with C57BL/6NJ (Stock No. 005304) to establish the colony.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 005304 C57BL/6NJ | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of APOE
004632 B6.Cg-Tg(GFAP-APOE*2)14Hol Apoetm1Unc/J 004631 B6.Cg-Tg(GFAP-APOE*4)1Hol Apoetm1Unc/J 008408 B6;D2-Tg(APOE-NPC1L1)20Lqyu/J 003285 C57BL/6-Tg(LIPC)6784His/J View Strains carrying other alleles of APOE (4 strains)
Strains carrying other alleles of DGAT2
006781 C57BL/6-Tg(Ckm-DGAT2)10Far/J View Strains carrying other alleles of DGAT2 (1 strain)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(APOE-DGAT2)24Far/0
involves: C57BL/6NHsd
- liver/biliary system phenotype
- enlarged liver (MGI Ref ID J:124005)
- resulting from steatosis; liver weight to body weight ratio (0.047) is higher than in wild-type mice
- hepatic steatosis (MGI Ref ID J:124005)
- steatosis exhibited by increase in size and paleness of livers
- pale liver (MGI Ref ID J:124005)
- due to lipid deposits resulting from steatosis
- homeostasis/metabolism phenotype
- *normal* homeostasis/metabolism phenotype (MGI Ref ID J:124005)
- food intake and body composition are not altered compared to wild-type animals
- plasma levels of adipokines and inflammatory cytokines are similar to wild-type mice
- blood glucose and insulin levels are similar to wild-type mice; transgenic mice do not display differences in glucose or insulin tolerance so mice are not insulin resistant
- following feeding of a high-fat diet for 16 weeks, transgenic and control mice show similar degree of impairment of glucose tolerance and insulin resistance
- abnormal circulating enzyme level (MGI Ref ID J:124005)
- plasma transaminase levels are slightly elevated relative to wild-type
- abnormal lipid level (MGI Ref ID J:124005)
- tissue content of diacylglycerol and ceramides are increased in liver; ; however, levels in skeletal muscle are not altered
- abnormal fatty acid level (MGI Ref ID J:124005)
- content of unsaturated long-chain fatty acyl-CoAs are increased in the liver, but levels of saturated long-chain fatty acyl-CoAs are not
- decreased circulating free fatty acid level (MGI Ref ID J:124005)
- plasma levels are slightly decreased relative to wild-type
- decreased circulating triglyceride level (MGI Ref ID J:124005)
- plasma triglyceride levels in fasted mice are decreased by >65% relative to controls
- increased triglyceride level (MGI Ref ID J:124005)
- triglyceride content is increased ~5-fold over wild-type
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
APOE relatedCardiovascular Research
Hypertriglyceridemia
Other (altered fat metabolism)
Other (altered lipoprotein profile)
Internal/Organ Research
Liver Defects
Metabolism Research
Lipid Metabolism
Research Tools
Cardiovascular Research
Diabetes and Obesity Research
Internal/Organ Research
Metabolism Research
Mouse/Human Gene Homologs
Alzheimer's
| Allele Symbol | Tg(APOE-DGAT2)24Far | ||
|---|---|---|---|
| Allele Name | transgene insertion 24, Bob Farese | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | Liv-DGAT2-low; LivLe6-DGAT2 (low); | ||
| Mutation Made By | Mara Monetti, Gladstone Institute UCSF | ||
| Strain of Origin | C57BL/6NHsd | ||
| Expressed Gene | DGAT2, diacylglycerol O-acyltransferase homolog 2 (mouse), human | ||
| Promoter | APOE, apolipoprotein E, human | ||
| Molecular Note | The LivLE6-DGAT2 transgene was designed with promoter and enhancer sequences of the human apolipoprotein E gene placed upstream of a 1.2 kb human acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2) cDNA sequence. This transgene was microinjected into C57BL/6NHsd fertilized eggs, and the resulting transgenic offspring were bred to C57BL/6NHsd. Mice from founder line 24 (referred to as Liv-DGAT2-low) have an approximately 2-fold increase in total hepatic DGAT2 mRNA/protein expression, with no reported overexpression in kidney, brain, or skeletal muscle. [MGI Ref ID J:124005] | ||
Genotyping Protocols
Tg(APOE-DGAT2)24Far, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV Sr; Hevener AL; Farese RV Jr. 2007. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6(1):69-78. [PubMed: 17618857] [MGI Ref ID J:124005]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, transgenic mice can be bred to wildtype siblings. Alternatively, transgenic mice may be bred together, although a homozygous phenotype is not yet characterized (Jul-2007). Mating System Noncarrier x Hemizygote (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $236.40 Female or Male Hemizygous for Tg(APOE-DGAT2)24Far *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $288.65 Hemizygous for Tg(APOE-DGAT2)24Far x Noncarrier $288.65 Noncarrier x Hemizygous for Tg(APOE-DGAT2)24Far
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $307.40 Female or Male Hemizygous for Tg(APOE-DGAT2)24Far *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $375.30 Hemizygous for Tg(APOE-DGAT2)24Far x Noncarrier $375.30 Noncarrier x Hemizygous for Tg(APOE-DGAT2)24Far
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 005304 C57BL/6NJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.